Rash Of FDA Warning Letters Raises Questions For Cosmetics industry

摘要

The recent "cluster" of warning letters to cosmetics companies for overreaching claims is "worth paying attention to" but not necessarily a sign that the agency is ramping up its enforcement efforts, according to EAS Consulting Group Expert Consultant John Bailey, previously chief scientist at the Personal Care Products Council and a former director of FDA's cosmetics program. Oct. 5 warning letters to Avon Products, Inc. - citing claims on the firm's website for A new anti-aging facial products, among others - and Blacksburg, Va.-based Bioque Technologies are the latest in the spate of letters to cosmetics firms over a roughly 30-day period (see related story, p. 6).